# RQ Bio funding rounds and investors

As of 14 Oct 2026, RQ Bio has raised $115M across 1 verified round on record; latest: $115 million (£85.5 million) Series A led by Frazier Life Sciences, announced 24 Jun 2026.

Headquarters: London, United Kingdom  
Page: https://fireround.dev/companies/rq-bio

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-06-24 | Series A | $115 million (£85.5 million) | Frazier Life Sciences | EQT Life Sciences, Forbion, LifeArc Ventures, Monograph, Oxford Science Enterprises, University of Oxford, Wellington Management | [globenewswire.com](https://www.globenewswire.com/news-release/2026/06/24/3316603/0/en/rq-bio-announces-115-million-85-5-million-series-a-financing-to-advance-long-acting-antibody-programme-rqb01-for-full-season-influenza-prevention.html), [fiercebiotech.com](https://www.fiercebiotech.com/biotech/rq-bio-reels-115m-take-long-acting-flu-prevention-antiviral-clinic), [forbion.com](https://forbion.com/news-insights/news/forbion-announces-participation-in-rq-bio-s-115-million-855-million-series-a-financing-to-advance-long-acting-antibody-programme-rqb01-for-full-season-influenza-prevention) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.